Group 2 innate lymphoid cells (ILC2s) play key roles in allergic asthma development. We have previously discovered that CD5 antigen-like protein (CD5L) can inhibit allergic airway inflammation. In this study, we investigate the effect of CD5L on ILC2s and the underlying mechanism.
Results:
Our findings demonstrated that CD5L suppresses allergic airway inflammation by inhibiting ILC2s. CD5L inhibited NF-κB, MAPK, and PI3K-AKT pathways in ILC2s, thus reducing interleukin (IL)-5 and IL-13 production. CD5L increased the level of lysophosphatidylcholine (lysoPC) in ILC2s through the transforming growth factor beta (TGF-β) signaling pathway. The elevated lysoPC further induced reactive oxygen species (ROS) production in ILC2s, and the increased ROS fed back to increase the level of lysoPC. The accumulated ROS induced ILC2 apoptosis. The scavenger receptor CD36 mediated the inhibitory effect of CD5L on ILC2s and allergic airway inflammation. Finally, CD5L was shown to be potential therapeutic for allergic asthma.
Innovation:
This study is the first to demonstrate that CD5L suppresses allergic airway inflammation by inhibiting ILC2 responses. It is the initial discovery that CD5L promotes ILC2 apoptosis, whereas CD5L was previously recognized as an apoptosis inhibitor. The regulation of TGF-β signaling pathway on lysoPC is demonstrated for the first time.
Conclusion:
This study demonstrated that CD5L inhibits ILC2 activation and induces ILC2 apoptosis, thereby suppressing allergic airway inflammation. CD5L can serve as a novel therapeutic strategy for allergic asthma. Antioxid. Redox Signal. 44, 393–409.
AotoM, ShinzawaK, SuzukiY, et al.Essential role of p38 MAPK in caspase-independent, iPLA(2)-dependent cell death under hypoxia/low glucose conditions. FEBS Lett, 2009; 583(10):1611–1618; doi: 10.1016/j.febslet.2009.04.028
2.
AraiS, SheltonJM, ChenM, et al.A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab, 2005; 1(3):201–213.
3.
AstudilloAM, BalboaMA, BalsindeJ. Compartmentalized regulation of lipid signaling in oxidative stress and inflammation: Plasmalogens, oxidized lipids and ferroptosis as new paradigms of bioactive lipid research. Prog Lipid Res, 2023; 89:101207; doi: 10.1016/j.plipres.2022.101207
4.
BartemesKR, KitaH. Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s. J Allergy Clin Immunol, 2021; 147(5):1531–1547; doi: 10.1016/j.jaci.2021.03.015
5.
BrandsmaJ, SchofieldJPR, YangX, et al.; U-BIOPRED Study Group. Stratification of asthma by lipidomic profiling of induced sputum supernatant. J Allergy Clin Immunol, 2023; 152(1):117–125; doi: 10.1016/j.jaci.2023.02.032
6.
ChenY, ZhangJ, CuiW, et al.CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med, 2022; 219(6):e20211314; doi: 10.1084/jem.20211314
7.
ChitrajuC, MejhertN, HaasJT, et al.Triglyceride synthesis by DGAT1 protects adipocytes from lipid-induced ER stress during lipolysis. Cell Metab, 2017; 26(2):407–418.e3; doi: 10.1016/j.cmet.2017.07.012
DenneyL, ByrneAJ, SheaTJ, et al.Pulmonary epithelial cell-derived cytokine TGF-β1 Is a Critical cofactor for enhanced innate lymphoid cell function. Immunity, 2015; 43(5):945–958; doi: 10.1016/j.immuni.2015.10.012
10.
FaliT, AychekT, FerhatM, et al.Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue. Mucosal Immunol, 2021; 14(3):585–593; doi: 10.1038/s41385-020-00351-w
11.
GaoW. Effect of budesonide combined with montelukast on children with asthma against thrombin III, CD5 antigen like protein and NLRP3 inflammatory bodies. Journal of Hubei University of Science and Technology, 2021; 35(05):425–427. in chinese.
12.
GaoW, QinX, ZhangJ, et al.Value of interleukin-35, highmobility group box 1, and CD5 antigen-like protein in evaluating the condition and prognosis of children with asthma. Journal of Qingdao University, 2020; 56(02):233–236. (in chinese).
13.
GuoL, JunttilaIS, PaulWE. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol, 2012; 33(12):598–606; doi: 10.1016/j.it.2012.07.006
14.
GusachA, LugininaA, MarinE, et al.Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun, 2019; 10(1):5573; doi: 10.1038/s41467-019-13348-2
HeJ, JiangG, LiX, et al.Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation. Mucosal Immunol, 2022; 15(2):314–326; doi: 10.1038/s41385-021-00460-0
17.
HelouDG, Shafiei-JahaniP, HurrellBP, et al.LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. J Allergy Clin Immunol, 2022; 149(1):223–236.e6; doi: 10.1016/j.jaci.2021.05.042
18.
HjelmsøMH, ShahSA, ThorsenJ, et al.Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial. Nat Commun, 2020; 11(1):426; doi: 10.1038/s41467-020-14308-x
19.
HsuJ-H, WuJ-R, LiouS-F, et al.Labedipinedilol-A prevents lysophosphatidylcholine-induced vascular smooth muscle cell death through reducing reactive oxygen species production and anti-apoptosis. Atherosclerosis, 2011; 217(2):379–386; doi: 10.1016/j.atherosclerosis.2011.04.022
20.
IwamuraY, MoriM, NakashimaK, et al.Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem Biophys Res Commun, 2012; 422(3):476–481; doi: 10.1016/j.bbrc.2012.05.018
21.
JohnsonRK, MankeJ, CampbellM, et al.Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects. J Allergy Clin Immunol, 2022; 150(4):965–971.e8; doi: 10.1016/j.jaci.2022.02.026
22.
KabataH, MoroK, KoyasuS. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev, 2018; 286(1):37–52; doi: 10.1111/imr.12706
23.
KaragiannisF, MasoulehS, WunderlingK, et al.Lipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation. Immunity, 2020; 52(4):620–634.e6; doi: 10.1016/j.immuni.2020.03.003
24.
Klein WolterinkRGJ, SerafiniN, van NimwegenM, et al.Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proceedings of the National Academy of Sciences of the United States of America, 2013; 110(25):10240–10245; doi: 10.1073/pnas.1217158110
25.
KurokawaJ, AraiS, NakashimaK, et al.Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab, 2010; 11(6):479–492; doi: 10.1016/j.cmet.2010.04.013
26.
LaFargueCJ, AmeroP, NohK, et al.Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nat Commun, 2023; 14(1):2407; doi: 10.1038/s41467-023-36910-5
27.
LambrechtBN, HammadH, FahyJV. The Cytokines of Asthma. Immunity, 2019; 50(4):975–991; doi: 10.1016/j.immuni.2019.03.018
28.
LeiA-H, XiaoQ, LiuG-Y, et al.ICAM-1 controls development and function of ILC2. J Exp Med, 2018; 215(8):2157–2174; doi: 10.1084/jem.20172359
29.
LeutiA, FazioD, FavaM, et al.Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev, 2020; 159:133–169; doi: 10.1016/j.addr.2020.06.028
30.
LiY, QuP, WuL, et al.Api6/AIM/Spα/CD5L overexpression in alveolar type II epithelial cells induces spontaneous lung adenocarcinoma. Cancer Res, 2011; 71(16):5488–5499; doi: 10.1158/0008-5472.CAN-10-4225
31.
LuJ-C, WuL-L, SunY-N, et al.Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. Nat Commun, 2024; 15(1):621; doi: 10.1038/s41467-024-44795-1
32.
MarraF, Svegliati-BaroniG. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol, 2018; 68(2):280–295; doi: 10.1016/j.jhep.2017.11.014
33.
MartinezV, Escoda-FerranC, Tadeu SimõesI, et al.The macrophage soluble receptor AIM/Api6/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression. Cell Mol Immunol, 2014; 11(4):343–354; doi: 10.1038/cmi.2014.12
34.
NandiAA, WadhwaniNS, JoshiSR. Altered metabolic homeostasis between vitamin D and long chain polyunsaturated fatty acids in preeclampsia. Med Hypotheses, 2017; 100:31–36; doi: 10.1016/j.mehy.2017.01.009
35.
NemotoH, HonjoM, AraiS, et al.Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension. J Cell Physiol, 2023; 238(10):2451–2467; doi: 10.1002/jcp.31097
36.
OgasawaraN, PoposkiJA, KlinglerAI, et al.IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol, 2018; 141(3):1147–1151.e8; doi: 10.1016/j.jaci.2017.09.025
37.
OliveiraL, SilvaMC, GomesAP, et al.CD5L as a promising biological therapeutic for treating sepsis. Nat Commun, 2024; 15(1):4119; doi: 10.1038/s41467-024-48360-8
38.
PalomerX, Pizarro-DelgadoJ, BarrosoE, et al.Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus. Trends Endocrinol Metab, 2018; 29(3):178–190; doi: 10.1016/j.tem.2017.11.009
39.
PeinH, VilleA, PaceS, et al.Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase. Nat Commun, 2018; 9(1):3834; doi: 10.1038/s41467-018-06158-5
40.
PepinoMY, KudaO, SamovskiD, et al.Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu Rev Nutr, 2014; 34:281–303; doi: 10.1146/annurev-nutr-071812-161220
41.
PetrovaT, PesicJ, PardaliK, et al.p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells. Sci Rep, 2020; 10(1):3479; doi: 10.1038/s41598-020-60089-0
42.
PokharelMD, MarcianoDP, FuP, et al.Metabolic reprogramming, oxidative stress, and pulmonary hypertension. Redox Biol, 2023; 64:102797; doi: 10.1016/j.redox.2023.102797
43.
RigasD, LewisG, AronJL, et al.Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction. J Allergy Clin Immunol, 2017; 139(5):1468–1477.e2; doi: 10.1016/j.jaci.2016.08.034
44.
SakanoY, SakanoK, HurrellBP, et al.Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity. J Allergy Clin Immunol, 2024; 153(5):1406–1422.e6; doi: 10.1016/j.jaci.2024.01.003
45.
SamuchiwalSK, BoyceJA. Role of lipid mediators and control of lymphocyte responses in type 2 immunopathology. J Allergy Clin Immunol, 2018; 141(4):1182–1190; doi: 10.1016/j.jaci.2018.02.006
46.
Sanchez-MoralL, PaulT, MartoriC, et al.Macrophage CD5L is a target for cancer immunotherapy. EBioMedicine, 2023; 91:104555; doi: 10.1016/j.ebiom.2023.104555
47.
SanjurjoL, AmézagaN, AranG, et al.The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses. Autophagy, 2015; 11(3):487–502; doi: 10.1080/15548627.2015.1017183
48.
StalenhoefJE, van NieuwkoopC, WilsonDC, et al.Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection. J Infect, 2018; 77(1):18–24; doi: 10.1016/j.jinf.2018.05.007
49.
SueajaiJ, SutjaritN, BoonmuenN, et al.Lowering of lysophosphatidylcholines in ovariectomized rats by Curcuma comosa. PLoS One, 2022; 17(5):e0268179; doi: 10.1371/journal.pone.0268179
50.
SuzukiM, MoritaR, HirataY, et al.Spred1, a suppressor of the Ras-ERK pathway, negatively regulates expansion and function of group 2 innate lymphoid cells. J Immunol, 2015; 195(3):1273–1281; doi: 10.4049/jimmunol.1500531
51.
ThioCL-P, ChiP-Y, LaiAC-Y, et al.Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate. J Allergy Clin Immunol, 2018; 142(6):1867–1883.e12; doi: 10.1016/j.jaci.2018.02.032
52.
WangC, YosefN, GaublommeJ, et al.CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity. Cell, 2015; 163(6):1413–1427; doi: 10.1016/j.cell.2015.10.068
53.
WangH, ShenX, LiuJ, et al.The effect of exposure time and concentration of airborne PM2.5 on lung injury in mice: A transcriptome analysis. Redox Biol, 2019; 26:101264; doi: 10.1016/j.redox.2019.101264
54.
WangL, LuoY, LuoL, et al.Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling. J Exp Med, 2021; 218(2):e20191054; doi: 10.1084/jem.20191054
55.
WengD, GaoS, ShenH, et al.CD5L attenuates allergic airway inflammation by expanding CD11c alveolar macrophages and inhibiting NLRP3 inflammasome activation via HDAC2. Immunology, 2022; 167(3):384–397; doi: 10.1111/imm.13543
56.
WilhelmC, HarrisonOJ, SchmittV, et al.Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J Exp Med, 2016; 213(8):1409–1418; doi: 10.1084/jem.20151448
57.
XuD, LiuL, ZhaoY, et al.Melatonin protects mouse testes from palmitic acid-induced lipotoxicity by attenuating oxidative stress and DNA damage in a SIRT1-dependent manner. J Pineal Res, 2020; 69(4):e12690; doi: 10.1111/jpi.12690
58.
YagiR, ZhongC, NorthrupDL, et al.The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells. Immunity, 2014; 40(3):378–388; doi: 10.1016/j.immuni.2014.01.012
59.
YamamotoT, EndoY, OnoderaA, et al.DUSP10 constrains innate IL-33-mediated cytokine production in ST2hi memory-type pathogenic Th2 cells. Nat Commun, 2018; 9(1):4231; doi: 10.1038/s41467-018-06468-8
60.
YasudaY, YoshinagaN, MurayamaT, et al.Inhibition of hydrogen peroxide-induced apoptosis but not arachidonic acid release in GH3 cell by EGF. Brain Res, 1999; 850(1–2):197–206.
61.
YasunariK, MaedaK, MinamiM, et al.HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscler Thromb Vasc Biol, 2001; 21(6):937–942.
62.
YoonB-K, KangY-H, OhW-J, et al.Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells. J Korean Med Sci, 2012; 27(7):803–810; doi: 10.3346/jkms.2012.27.7.803
63.
YuM, JiaH-M, CuiF-X, et al.The effect of chinese herbal medicine formula mkg on allergic asthma by regulating lung and plasma metabolic alternations. Int J Mol Sci, 2017; 18(3):602; doi: 10.3390/ijms18030602
64.
YusaS, OhnishiS, OnoderaT, et al.AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-beta1. Eur J Immunol, 1999; 29(4):1086–1093.
65.
ZhangL, LiuX, LiuY, et al.Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5. Clin Transl Med, 2023; 13(1):e1180; doi: 10.1002/ctm2.1180
66.
ZhangQ, ShenX, YuanX, et al.Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis. Nat Commun, 2024; 15(1):3213; doi: 10.1038/s41467-024-47553-5
67.
ZhouW, TokiS, ZhangJ, et al.Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses. Am J Respir Crit Care Med, 2016; 193(1):31–42; doi: 10.1164/rccm.201410-1793OC
68.
ZhouY, WangW, ZhaoC, et al.Prostaglandin E2 inhibits group 2 innate lymphoid cell activation and allergic airway inflammation through e-prostanoid 4-cyclic adenosine monophosphate signaling. Front Immunol, 2018; 9:501; doi: 10.3389/fimmu.2018.00501
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
